Loading...

Rite Aid

DB:RTA
Snowflake Description

Fair value with mediocre balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
RTA
DB
$519M
Market Cap
  1. Home
  2. DE
  3. Consumer Retailing
Company description

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The last earnings update was 11 days ago. More info.


Add to Portfolio Compare Print
  • Rite Aid has significant price volatility in the past 3 months.
RTA Share Price and Events
7 Day Returns
-4.3%
DB:RTA
0.3%
Europe Consumer Retailing
1.8%
DE Market
1 Year Returns
-98.4%
DB:RTA
1.5%
Europe Consumer Retailing
-6%
DE Market
RTA Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Rite Aid (RTA) -4.3% -96.5% -97.5% -98.4% -99.7% -99.6%
Europe Consumer Retailing 0.3% -0.1% 2.8% 1.5% -4.6% -7.6%
DE Market 1.8% 6% 7.8% -6% 10.1% 15.3%
1 Year Return vs Industry and Market
  • RTA underperformed the Consumer Retailing industry which returned 1.5% over the past year.
  • RTA underperformed the Market in Germany which returned -6% over the past year.
Price Volatility
RTA
Industry
5yr Volatility vs Market

RTA Value

 Is Rite Aid undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Rite Aid to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Rite Aid.

DB:RTA Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 5 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 12.1%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:RTA
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.2%
Equity Risk Premium S&P Global 6%
Consumer Retailing Unlevered Beta Simply Wall St/ S&P Global 0.48
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.483 (1 + (1- 21%) (673.23%))
2.374
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
2
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.23% + (2 * 5.96%)
12.15%

Discounted Cash Flow Calculation for DB:RTA using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Rite Aid is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

DB:RTA DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 12.15%)
2019 91.00 Analyst x1 81.14
2020 313.00 Analyst x1 248.86
2021 367.14 Est @ 17.3% 260.29
2022 411.84 Est @ 12.18% 260.35
2023 447.22 Est @ 8.59% 252.09
2024 474.42 Est @ 6.08% 238.46
2025 494.94 Est @ 4.33% 221.83
2026 510.27 Est @ 3.1% 203.92
2027 521.68 Est @ 2.24% 185.90
2028 530.20 Est @ 1.63% 168.47
Present value of next 10 years cash flows $2,121.32
DB:RTA DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= $530.20 × (1 + 0.23%) ÷ (12.15% – 0.23%)
$4,458.14
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $4,458.14 ÷ (1 + 12.15%)10
$1,416.57
DB:RTA Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $2,121.32 + $1,416.57
$3,537.89
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $3,537.89 / 53.41
$66.25
DB:RTA Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:RTA represents 0.03916x of NYSE:RAD
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.03916x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (USD) x Listing Adjustment Factor
= $ 66.25 x 0.03916
€2.59
Value per share (EUR) From above. €2.59
Current discount Discount to share price of €0.42
= -1 x (€0.42 - €2.59) / €2.59
83.8%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Rite Aid is available for.
Intrinsic value
>50%
Share price is €0.42 vs Future cash flow value of €2.59
Current Discount Checks
For Rite Aid to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Rite Aid's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Rite Aid's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Rite Aid's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Rite Aid's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:RTA PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-02) in USD $-12.62
NYSE:RAD Share Price ** NYSE (2019-04-18) in USD $10.75
Europe Consumer Retailing Industry PE Ratio Median Figure of 32 Publicly-Listed Consumer Retailing Companies 19.38x
Germany Market PE Ratio Median Figure of 424 Publicly-Listed Companies 19.59x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Rite Aid.

DB:RTA PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:RAD Share Price ÷ EPS (both in USD)

= 10.75 ÷ -12.62

-0.85x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Rite Aid is loss making, we can't compare its value to the Europe Consumer Retailing industry average.
  • Rite Aid is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does Rite Aid's expected growth come at a high price?
Raw Data
DB:RTA PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -0.85x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 5 Analysts
Not available
Europe Consumer Retailing Industry PEG Ratio Median Figure of 24 Publicly-Listed Consumer Retailing Companies 1.71x
Germany Market PEG Ratio Median Figure of 270 Publicly-Listed Companies 1.56x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Rite Aid, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Rite Aid's assets?
Raw Data
DB:RTA PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-02) in USD $22.22
NYSE:RAD Share Price * NYSE (2019-04-18) in USD $10.75
Europe Consumer Retailing Industry PB Ratio Median Figure of 41 Publicly-Listed Consumer Retailing Companies 1.58x
Germany Market PB Ratio Median Figure of 574 Publicly-Listed Companies 1.84x
DB:RTA PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:RAD Share Price ÷ Book Value per Share (both in USD)

= 10.75 ÷ 22.22

0.48x

* Primary Listing of Rite Aid.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Rite Aid is good value based on assets compared to the Europe Consumer Retailing industry average.
X
Value checks
We assess Rite Aid's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Consumer Retailing industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Consumer Retailing industry average (and greater than 0)? (1 check)
  5. Rite Aid has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

RTA Future Performance

 How is Rite Aid expected to perform in the next 1 to 3 years based on estimates from 5 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
-0.3%
Expected annual growth in revenue.
Earnings growth vs Low Risk Savings
Is Rite Aid expected to grow at an attractive rate?
  • Unable to compare Rite Aid's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Rite Aid's earnings growth to the Germany market average as no estimate data is available.
  • Rite Aid's revenues are expected to decrease over the next 1-3 years, this is below the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:RTA Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:RTA Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 5 Analysts -0.3%
Europe Consumer Retailing Industry Earnings Growth Rate Market Cap Weighted Average 12%
Europe Consumer Retailing Industry Revenue Growth Rate Market Cap Weighted Average 3.8%
Germany Market Earnings Growth Rate Market Cap Weighted Average 11.6%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:RTA Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:RTA Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-02-28 21,404 2
2021-02-28 21,601 3
2020-02-29 21,595 249 -166 5
DB:RTA Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-03-02 21,640 -229 -667
2018-12-01 21,654 -93 -895
2018-09-01 21,557 -394 -896
2018-06-02 21,481 83 -355
2018-03-03 21,529 266 -350
2017-12-02 22,038 423 109
2017-09-02 22,354 511 151
2017-06-03 20,180 165 -27
2017-03-04 22,928 232 4
2016-11-26 25,294 500 95
2016-08-27 27,779 675 131
2016-05-28 32,273 790 142

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Rite Aid is high growth as no earnings estimate data is available.
  • Rite Aid's revenue is expected to decrease over the next 1-3 years, this is not considered high growth.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:RTA Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below

All data from Rite Aid Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:RTA Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-02-28
2021-02-28
2020-02-29 -3.10 -3.00 -3.21 2.00
DB:RTA Past Financials Data
Date (Data in USD Millions) EPS *
2019-03-02 -12.62
2018-12-01 -16.95
2018-09-01 -17.01
2018-06-02 -6.76
2018-03-03 -6.66
2017-12-02 2.08
2017-09-02 2.88
2017-06-03 -0.52
2017-03-04 0.08
2016-11-26 1.82
2016-08-27 2.51
2016-05-28 2.74

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Rite Aid will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Rite Aid's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Rite Aid has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

RTA Past Performance

  How has Rite Aid performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Rite Aid's growth in the last year to its industry (Consumer Retailing).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Rite Aid does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Rite Aid's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Rite Aid's 1-year growth to the Europe Consumer Retailing industry average as it is not currently profitable.
Earnings and Revenue History
Rite Aid's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Rite Aid Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:RTA Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-02 21,639.56 -666.95 4,574.38
2018-12-01 21,654.18 -895.00 4,600.02
2018-09-01 21,557.29 -895.93 4,637.10
2018-06-02 21,480.94 -355.22 4,642.95
2018-03-03 21,528.97 -349.53 4,651.26
2017-12-02 22,038.09 109.09 4,705.17
2017-09-02 22,354.03 150.88 4,730.58
2017-06-03 20,179.88 -27.37 4,144.69
2017-03-04 22,927.54 4.08 4,777.00
2016-11-26 25,294.29 94.75 5,306.66
2016-08-27 27,779.36 130.68 5,909.66
2016-05-28 32,273.28 142.04 7,079.53
2016-02-27 20,770.24 102.09 4,581.17
2015-11-28 29,314.45 1,934.88 6,905.94
2015-08-29 27,852.60 1,980.18 6,820.73
2015-05-30 26,710.41 2,086.56 6,735.43
2015-02-28 26,528.38 2,109.17 6,680.20
2014-11-29 26,277.91 329.52 6,693.99
2014-08-30 25,943.31 267.78 6,633.85
2014-05-31 25,698.89 169.96 6,596.26
2014-03-01 25,526.41 215.42 6,561.16
2013-11-30 25,384.20 280.41 6,526.82
2013-08-31 25,264.31 296.50 6,545.72
2013-06-01 25,217.03 225.07 6,560.96
2013-03-02 25,392.26 107.48 6,618.87
2012-12-01 26,083.77 -176.71 6,694.86
2012-09-01 26,158.51 -290.41 6,626.76
2012-06-02 26,198.72 -343.75 6,612.34

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Rite Aid has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Rite Aid has efficiently used its assets last year compared to the Europe Consumer Retailing industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Rite Aid improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Rite Aid's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Consumer Retailing industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Rite Aid has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

RTA Health

 How is Rite Aid's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Rite Aid's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Rite Aid is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Rite Aid's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Rite Aid's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Rite Aid Company Filings, last reported 1 month ago.

DB:RTA Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-02 1,186.69 3,494.76 144.35
2018-12-01 1,453.41 3,436.73 417.25
2018-09-01 1,455.95 3,526.95 132.47
2018-06-02 1,812.31 3,182.60 147.09
2018-03-03 1,601.01 3,391.64 447.33
2017-12-02 825.14 3,037.71 169.80
2017-09-02 733.61 7,142.93 238.98
2017-06-03 560.63 7,240.27 221.47
2017-03-04 614.07 3,290.80 252.28
2016-11-26 646.13 7,274.91 226.92
2016-08-27 616.67 7,244.70 142.29
2016-05-28 591.50 6,974.40 144.84
2016-02-27 581.43 6,994.14 124.47
2015-11-28 500.83 7,367.48 226.25
2015-08-29 429.70 7,444.31 152.65
2015-05-30 152.73 7,234.87 1,922.13
2015-02-28 57.06 5,559.12 115.90
2014-11-29 -1,792.66 5,850.69 232.95
2014-08-30 -1,906.53 5,752.29 185.76
2014-05-31 -2,046.35 5,704.39 166.00
2014-03-01 -2,113.70 5,757.14 146.41
2013-11-30 -2,228.83 5,952.43 183.21
2013-08-31 -2,317.87 6,051.56 144.17
2013-06-01 -2,357.52 5,911.67 108.90
2013-03-02 -2,459.43 6,033.53 129.45
2012-12-01 -2,576.11 6,152.41 263.64
2012-09-01 -2,643.32 6,158.91 94.33
2012-06-02 -2,609.33 6,163.41 214.77
  • Rite Aid's level of debt (294.5%) compared to net worth is high (greater than 40%).
  • Rite Aid had negative shareholder equity 5 years ago, it is now positive therefore their debt level has improved.
  • Operating cash flow is negative therefore debt is not well covered.
  • Rite Aid is making a loss, therefore interest payments are not well covered by earnings.
X
Financial health checks
We assess Rite Aid's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Rite Aid has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

RTA Dividends

 What is Rite Aid's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Rite Aid dividends. Estimated to be 0% next year.
If you bought €2,000 of Rite Aid shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Rite Aid's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Rite Aid's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:RTA Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below
Europe Consumer Retailing Industry Average Dividend Yield Market Cap Weighted Average of 34 Stocks 3.7%
Germany Market Average Dividend Yield Market Cap Weighted Average of 327 Stocks 3%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.4%
Germany Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:RTA Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2022-02-28 0.00 1.00
2021-02-28 0.00 2.00
2020-02-29 0.00 2.00

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Rite Aid has not reported any payouts.
  • Unable to verify if Rite Aid's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Rite Aid's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Rite Aid has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Rite Aid's dividends in 3 years as they are not expected to pay a notable one for Germany.
X
Income/ dividend checks
We assess Rite Aid's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Rite Aid afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Rite Aid has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

RTA Management

 What is the CEO of Rite Aid's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
John Standley
COMPENSATION $9,320,462
AGE 55
TENURE AS CEO 8.8 years
CEO Bio

Mr. John T. Standley has been the Chief Executive Officer of Rite Aid Corporation since June 24, 2010. Mr. Standley served as the President of Rite Aid Corporation from September 25, 2008 to June 2013 and its Chief Operating Officer from September 2008 to June 2010. He served as the Chief Executive Officer of Pathmark Stores Inc. from August 29, 2005 to December 2007. Mr. Standley served as the Chief Financial Officer of Rite Aid Corp. from January 9, 2004 to August 2005 and served as its Senior Executive Vice President and Chief Administrative Officer from June 2002 to August 2005. He also served as a Consultant to Rite Aid from July 2008 to September 2008. He served as Senior Executive Vice President and Chief Financial Officer of Rite Aid Corporation from September 2000 to June 2002 and served as its Executive Vice President and Chief Financial Officer from December 1999 to September 2000. Mr. Standley served as an Executive Vice President and Chief Financial Officer of Fleming Companies Inc., a food marketing and distribution company from May 1999 to December 1999. Mr. Standley worked with The Yucaipa Companies to combine several regional grocery companies into Fred Meyer, Inc., from 1994 to 1999. From July 1998 to May 1999, he served as Senior Vice President and Chief Financial Officer of Fred Meyer, Inc. He served as Senior Vice President and Chief Financial Officer of Ralphs Grocery Company (Food 4 Less Holdings, Inc.) from January 1997 to July 1998. He has more than 30 years of retail, financial and executive experience and has an in-depth understanding of the food and drug retailing industries. Mr. Standley has spent the past 20 years in executive leadership roles in the grocery and pharmacy retail business. He served as Senior Vice President of Administration of Smith's Food & Drug Stores, Inc., from May 1996 to February 1997 and as Chief Financial Officer of Smitty's Supervalue, Inc., from December 1994 to May 1996. He has been the Chairman of National Association of Chain Drug Stores, Inc. since April 28, 2014 and serves as its Director. He served as a Vice Chairman of National Association of Chain Drug Stores, Inc. from April 2013 to April 28, 2014. He has been a Director of Rite Aid Corp. since June 2009. He served as a Director of CarMax Inc., from August 1, 2016 to January 29, 2018. He served as a Director of SUPERVALU Inc. from April 2013 to July 22, 2015. He was Chairman of Rite Aid Corporation from June 21, 2012 to October 30, 2018. He served as a Director of Pathmark Stores Inc. from August 2005 to December 2007. Mr. Standley is a Graduate of Pepperdine University.

CEO Compensation
  • John's compensation has increased whilst company is loss making.
  • John's remuneration is higher than average for companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the Rite Aid management team in years:

0.3
Average Tenure
53
Average Age
  • The average tenure for the Rite Aid management team is less than 2 years, this suggests a new team.
Management Team

John Standley

TITLE
CEO & Director
COMPENSATION
$9M
AGE
55
TENURE
8.8 yrs

Bryan Everett

TITLE
Chief Operating Officer
COMPENSATION
$3M
AGE
45
TENURE
0.1 yrs

Darren Karst

TITLE
Executive Officer
COMPENSATION
$4M
AGE
58
TENURE
0.1 yrs

Jocelyn Konrad

TITLE
Executive Vice President of Pharmacy & Retail Operations
COMPENSATION
$1M
AGE
48
TENURE
3.7 yrs

Matt Schroeder

TITLE
Chief Financial Officer
AGE
48
TENURE
0.1 yrs

Brian Hoover

TITLE
Chief Accounting Officer
AGE
53
TENURE
0.1 yrs

Justin Mennen

TITLE
Senior VP and Chief Information Officer
TENURE
0.3 yrs

Byron Purcell

TITLE
Senior Director of Treasury Services & Investor Relations

Jim Comitale

TITLE
Senior VP
TENURE
3.4 yrs

Susan Henderson

TITLE
Chief Communications Officer & Senior VP
AGE
65
TENURE
7.7 yrs
Board of Directors Tenure

Average tenure and age of the Rite Aid board of directors in years:

0.5
Average Tenure
63
Average Age
  • The average tenure for the Rite Aid board of directors is less than 3 years, this suggests a new board.
Board of Directors

Bruce Bodaken

TITLE
Chairman of the Board
COMPENSATION
$220K
AGE
66
TENURE
0.5 yrs

John Standley

TITLE
CEO & Director
COMPENSATION
$9M
AGE
55
TENURE
9.8 yrs

Marcy Syms

TITLE
Independent Director
COMPENSATION
$230K
AGE
67
TENURE
13.6 yrs

Kevin Lofton

TITLE
Independent Director
COMPENSATION
$230K
AGE
63
TENURE
5.4 yrs

Bob Knowling

TITLE
Independent Director
AGE
63
TENURE
0.5 yrs

Lou Miramontes

TITLE
AGE
63
TENURE
0.5 yrs

Arun Nayar

TITLE
Independent Director
AGE
67
TENURE
0.5 yrs

Busy Burr

TITLE
Independent Director
AGE
56

Kate Quinn

TITLE
Independent Director
AGE
53
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Rite Aid's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Rite Aid has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

RTA News

Simply Wall St News

RTA Company Info

Description

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. It also operates retail clinics that provide treatment for common conditions; and a range of preventive services comprising screenings, medical tests, immunizations, and basic physical exams. In addition, this segment offers healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; and offers integrated mail-order, specialty and compounding pharmacy, and infertility treatment services, as well as drug benefits under the federal government's Medicare Part D program. As of April 12, 2018, the company operated approximately 2,548 stores in 19 states. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.

Details
Name: Rite Aid Corporation
RTA
Exchange: DB
Founded: 1927
$461,066,348
53,405,550
Website: http://www.riteaid.com
Address: Rite Aid Corporation
30 Hunter Lane,
Camp Hill,
Pennsylvania, 17011,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE RAD Common Stock New York Stock Exchange US USD 07. Oct 1968
DB RTA Common Stock Deutsche Boerse AG DE EUR 07. Oct 1968
LSE 0KX4 Common Stock London Stock Exchange GB USD 07. Oct 1968
Number of employees
Current staff
Staff numbers
48,410
Rite Aid employees.
Industry
Drug Retail
Consumer Retailing
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/22 21:05
End of day share price update: 2019/04/18 00:00
Last estimates confirmation: 2019/04/22
Last earnings filing: 2019/04/11
Last earnings reported: 2019/03/02
Last annual earnings reported: 2019/03/02


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.